Complete Filing Data
Grace Therapeutics, Inc. reported Stockholders Equity of $67.96 million for FY2023.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Grace Therapeutics, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$9.6M | -$12.9M | -$42.4M | -$9.8M | -$19.7M | -$25.5M | -$39.4M | -$21.5M | -$769.0K | -$6.3M |
| Research And Development Expense | $9.5M | $4.7M | $10.0M | $5.6M | $4.2M | $16.0M | $29.4M | $15.7M | $426.0K | $7.6M |
| General And Administrative Expense | $7.2M | $6.7M | $7.6M | $9.3M | $5.5M | $5.8M | $4.5M | $4.0M | $292.0K | $2.0M |
| Operating Income Loss | -$16.7M | -$12.9M | -$52.2M | -$15.6M | -$16.4M | -$24.4M | -$34.4M | |||
| Nonoperating Income Expense | $3.9M | -$1.8M | $184.0K | $5.1M | -$3.3M | -$1.1M | -$5.0M | |||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$1.0K | $296.0K | $1.6M | -$752.0K | -$831.0K | |||||
| Selling And Marketing Expense | $252.0K | $661.0K | $518.0K | $1.1M | $2.7M | $494.0K | ||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$12.8M | -$14.7M | -$52.0M | -$10.5M | -$19.7M | |||||
| Income Tax Expense Benefit | -$3.2M | -$1.8M | -$9.5M | -$648.0K | $0.00 | |||||
| Deferred Income Tax Liabilities Net | $5.5M | $7.3M | $16.9M | |||||||
| Amortization Of Intangible Assets | $0.00 | $781.0K | $1.9M | $1.9M | ||||||
| Comprehensive Income Net Of Tax | -$9.6M | -$12.9M | ||||||||
| Restructuring And Related Cost Incurred Cost | $0.00 | $1.5M | $0.00 | |||||||
| Impairment Of Intangible Assets Finitelived | $0.00 | $28.7M | $0.00 | $3.7M | ||||||
| Impairment Of Long Lived Assets To Be Disposed Of | $0.00 | $1.6M | ||||||||
| Revenue From Contract With Customer Including Assessed Tax | $0.00 | $196.0K | ||||||||
| Cost Of Goods And Services Sold | $0.00 | $76.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$2.3M | -$938.0K | -$3.4M | -$4.2M | -$3.4M | -$2.6M | -$2.4M | -$3.3M | -$4.0M | -$3.9M | -$4.9M | -$4.5M | -$3.8M | $981.0K | -$3.1M | -$3.2M | -$6.1M | -$4.7M | -$25.5M | -$12.1M | -$21.2M | -$8.8M | -$39.4M | ||
| Research And Development Expense | $462.0K | $568.0K | $955.0K | $2.2M | $3.0M | $2.7M | $1.4M | $460.0K | $1.1M | $2.5M | $3.3M | $2.6M | $2.2M | $585.0K | $469.0K | $678.0K | $1.3M | $1.8M | $3.9M | $4.0M | $6.2M | ||||
| General And Administrative Expense | $2.0M | $2.0M | $2.1M | $1.5M | $1.9M | $2.3M | $1.6M | $1.6M | $1.9M | $1.6M | $1.7M | $1.9M | $1.8M | $3.0M | $2.7M | $1.1M | $1.3M | $1.6M | $1.6M | $1.6M | $1.1M | ||||
| Operating Income Loss | -$2.4M | -$2.5M | -$3.1M | -$3.7M | -$4.8M | -$5.0M | -$3.0M | -$2.1M | -$4.5M | -$4.2M | -$5.1M | -$4.7M | -$4.5M | -$3.6M | -$3.1M | -$2.0M | -$8.0M | -$4.1M | -$6.1M | -$6.3M | -$8.0M | ||||
| Nonoperating Income Expense | $134.0K | $1.6M | -$272.0K | -$1.1M | $547.0K | $1.6M | $444.0K | -$1.6M | $142.0K | $82.0K | $24.0K | -$36.0K | $696.0K | $4.5M | $27.0K | -$1.3M | $1.9M | -$545.0K | -$6.0M | -$14.9M | -$840.0K | ||||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $2.0K | -$1.0K | -$2.0K | $187.0K | -$1.1M | $762.0K | $466.0K | $179.0K | $308.0K | -$17.0K | -$64.0K | $51.0K | |||||||||||||
| Selling And Marketing Expense | $30.0K | $43.0K | $111.0K | $206.0K | $136.0K | $221.0K | $238.0K | $25.0K | $0.00 | $226.0K | $134.0K | $716.0K | $655.0K | $746.0K | $700.0K | ||||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$2.3M | -$938.0K | -$3.4M | -$4.8M | -$4.3M | -$3.3M | -$2.6M | -$3.7M | -$4.3M | -$4.2M | -$5.1M | -$4.8M | -$3.8M | $981.0K | -$3.1M | ||||||||||
| Income Tax Expense Benefit | $0.00 | $0.00 | $0.00 | -$605.0K | -$852.0K | -$724.0K | -$208.0K | -$446.0K | -$289.0K | -$274.0K | -$155.0K | -$242.0K | $0.00 | $0.00 | $0.00 | ||||||||||
| Deferred Income Tax Liabilities Net | $2.3M | $2.3M | $2.3M | $2.3M | $3.3M | $3.9M | $4.8M | $6.4M | $6.6M | $7.1M | $16.2M | $16.5M | $16.6M | ||||||||||||
| Amortization Of Intangible Assets | $0.00 | $0.00 | $0.00 | $0.00 | $319.0K | $462.0K | $1.9M | $485.0K | $482.0K | $481.0K | $1.9M | ||||||||||||||
| Comprehensive Income Net Of Tax | -$2.3M | -$938.0K | -$3.4M | -$4.2M | -$3.4M | -$2.6M | -$2.4M | -$3.3M | -$4.0M | ||||||||||||||||
| Restructuring And Related Cost Incurred Cost | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.5M | $0.00 | $0.00 | $0.00 | ||||||||||||||||
| Impairment Of Intangible Assets Finitelived | $0.00 | $0.00 | -$3.7M | $0.00 | $3.7M | ||||||||||||||||||||
| Impairment Of Long Lived Assets To Be Disposed Of | $250.0K | $0.00 | $0.00 | $0.00 | $1.6M | ||||||||||||||||||||
| Revenue From Contract With Customer Including Assessed Tax | $0.00 | $81.0K | |||||||||||||||||||||||
| Cost Of Goods And Services Sold | $0.00 | $36.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $68.0M | $108.3M | $55.7M | $13.0M | $11.0M | $7.2M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $30.3M | $50.9M | $14.2M | $16.9M | |||||
| Cash | $23.0M | $27.9M | $30.3M | $50.9M | $14.2M | $16.9M | $6.4M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$872.0K | -$4.9M | -$2.5M | -$20.6M | $36.7M | -$2.6M | |||
| Liabilities | $11.6M | $11.2M | $20.4M | $6.8M | $9.9M | $25.9M | $14.7M | $3.8M | |
| Assets | $73.3M | $79.1M | $128.6M | $62.5M | $22.9M | $36.9M | $23.0M | $25.5M | |
| Cash And Cash Equivalents At Carrying Value | $23.0M | $27.9M | $30.3M | $50.9M | $14.2M | $16.9M | $6.4M | ||
| Retained Earnings Accumulated Deficit | -$211.1M | -$198.3M | -$155.8M | -$146.0M | -$126.3M | -$100.8M | |||
| Liabilities Current | $1.7M | $3.4M | $3.3M | $1.6M | $7.4M | $13.7M | |||
| Liabilities And Stockholders Equity | $73.3M | $79.1M | $128.6M | $62.5M | $22.9M | $36.9M | |||
| Cash Equivalents At Carrying Value | $21.3M | $19.7M | $10.1M | $0.00 | $12.5M | $9.4M | $15.5M | ||
| Assets Current | $24.0M | $29.3M | $45.3M | $62.4M | $18.5M | $28.0M | |||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$6.0M | -$6.0M | -$6.0M | -$6.3M | -$7.9M | -$7.1M | |||
| Accounts Payable And Accrued Liabilities Current | $1.7M | $3.3M | $3.2M | $1.5M | $7.3M | $12.3M | |||
| Effect Of Translation Effect On Cash And Cash Equivalents | $0.00 | -$8.0K | $26.0K | $6.3M | -$254.0K | ||||
| Intangible Assets Net Excluding Goodwill | $41.1M | $41.1M | $69.8M | $4.2M | $6.4M | ||||
| Derivative Liabilities Noncurrent | $4.4M | $0.00 | $10.0K | $5.2M | $2.4M | $12.2M | |||
| Common Stock Value | $1.0K | $258.0M | $197.2M | $137.4M | $110.9M | ||||
| Receivables Net Current | $802.0K | $548.0K | $530.0K | $546.0K | $1.2M | ||||
| Operating Lease Right Of Use Asset | $0.00 | $463.0K | $315.0K | $86.0K | $147.0K | ||||
| Operating Lease Liability Current | $0.00 | $75.0K | $104.0K | $86.0K | $76.0K | ||||
| Goodwill | $8.1M | $8.1M | $13.0M | ||||||
| Short Term Investments | $15.0K | $13.3M | $9.8M | $8.9M | |||||
| Operating Lease Liability Noncurrent | $0.00 | $410.0K | $191.0K | $71.0K | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $27.9M | ||||||||
| Assets Of Disposal Group Including Discontinued Operation Current | $0.00 | $352.0K | $768.0K | $2.6M | |||||
| Write Off Of Deferred Financing Costs Of At The Market Program | $0.00 | $264.0K | |||||||
| Gain Loss On Sale Of Property Plant Equipment | $0.00 | $59.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $64.9M | $62.8M | $63.6M | $66.6M | $52.1M | $56.1M | $59.4M | $61.7M | $64.7M | $66.7M | $64.0M | $96.7M | $100.2M | $104.4M | $111.1M | $114.2M | $53.5M | $25.7M | $8.9M | $11.0M | -$4.3M | -$759.0K | $3.3M | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $19.4M | $23.0M | $18.5M | $21.6M | $27.9M | $26.2M | $26.2M | $38.4M | $33.0M | $36.9M | $41.0M | $26.5M | $11.6M | $12.1M | $19.8M | $19.5M | $16.0M | ||||||||||
| Cash | $18.7M | $16.9M | $20.0M | $22.1M | $11.1M | $15.2M | $19.4M | $18.5M | $27.0M | $21.6M | $26.2M | $34.9M | $38.4M | $33.0M | $36.9M | $41.0M | $26.5M | $11.6M | $12.1M | ||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$2.1M | -$3.6M | -$6.2M | $8.0M | -$3.9M | -$4.0M | -$10.0M | $15.0M | -$570.0K | -$2.1M | $271.0K | $3.5M | -$894.0K | ||||||||||||||
| Liabilities | $3.6M | $3.8M | $6.3M | $5.4M | $9.1M | $9.2M | $10.4M | $11.5M | $11.5M | $9.0M | $20.1M | $20.7M | $20.5M | $3.2M | $5.6M | $7.0M | $4.6M | $5.0M | $9.1M | ||||||||
| Assets | $68.5M | $66.6M | $69.8M | $72.0M | $61.2M | $65.3M | $69.7M | $76.2M | $78.2M | $73.0M | $116.8M | $120.9M | $124.9M | $114.2M | $119.8M | $60.5M | $30.3M | $13.8M | $20.1M | ||||||||
| Cash And Cash Equivalents At Carrying Value | $18.7M | $16.9M | $20.0M | $22.1M | $11.1M | $15.2M | $19.4M | $18.5M | $27.0M | $21.6M | $26.2M | $34.9M | $38.4M | $33.0M | $36.9M | $41.0M | $26.5M | $11.6M | $12.1M | ||||||||
| Retained Earnings Accumulated Deficit | -$227.3M | -$225.0M | -$224.0M | -$220.7M | -$221.3M | -$217.2M | -$213.7M | -$208.0M | -$205.6M | -$202.3M | -$169.2M | -$165.3M | -$160.4M | -$151.9M | -$148.2M | -$149.1M | -$140.4M | -$137.2M | -$131.0M | ||||||||
| Liabilities Current | $1.3M | $1.2M | $2.3M | $1.9M | $2.0M | $2.7M | $2.6M | $1.8M | $1.4M | $2.0M | $3.4M | $3.8M | $3.7M | $2.9M | $4.5M | $2.3M | $2.2M | $3.8M | $6.0M | ||||||||
| Liabilities And Stockholders Equity | $68.5M | $66.6M | $69.8M | $72.0M | $61.2M | $65.3M | $69.7M | $76.2M | $78.2M | $73.0M | $116.8M | $120.9M | $124.9M | $114.2M | $119.8M | $60.5M | $30.3M | $13.8M | $20.1M | ||||||||
| Cash Equivalents At Carrying Value | $17.5M | $15.0M | $18.1M | $10.2M | $14.1M | $16.4M | $16.5M | $16.4M | $16.2M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $19.4M | $5.5M | $6.9M | $12.9M | $16.9M | $14.9M | ||||||
| Assets Current | $19.2M | $17.3M | $20.5M | $22.7M | $11.9M | $16.1M | $20.4M | $26.9M | $28.9M | $23.6M | $33.4M | $37.5M | $41.2M | $49.0M | $54.5M | $60.4M | $30.2M | $13.7M | $14.0M | ||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$6.0M | -$6.0M | -$6.0M | -$6.0M | -$6.0M | -$6.0M | -$6.0M | -$6.0M | -$6.0M | -$6.0M | -$6.0M | -$6.0M | -$6.0M | -$6.5M | -$6.7M | -$5.6M | -$6.9M | -$7.4M | -$7.6M | ||||||||
| Accounts Payable And Accrued Liabilities Current | $1.3M | $1.2M | $2.3M | $1.9M | $2.0M | $2.7M | $2.6M | $1.7M | $1.4M | $1.9M | $3.4M | $3.7M | $3.1M | $2.8M | $4.4M | $2.3M | $2.1M | $3.7M | $5.9M | ||||||||
| Effect Of Translation Effect On Cash And Cash Equivalents | $0.00 | -$2.0K | $11.0K | $136.0K | $199.0K | -$511.0K | -$1.8M | -$31.0K | -$120.0K | -$747.0K | $260.0K | -$101.0K | $122.0K | -$1.0M | |||||||||||||
| Intangible Assets Net Excluding Goodwill | $41.1M | $41.1M | $41.1M | $41.1M | $41.1M | $41.1M | $41.1M | $41.1M | $41.1M | $41.1M | $69.8M | $69.8M | $69.8M | $65.2M | $65.2M | $0.00 | $3.9M | ||||||||||
| Derivative Liabilities Noncurrent | $201.0K | $1.6M | $1.1M | $3.8M | $2.6M | $3.0M | $3.3M | $3.5M | $0.00 | $0.00 | $268.0K | $1.1M | $4.7M | $2.3M | $1.2M | $3.1M | |||||||||||
| Common Stock Value | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $258.3M | $258.3M | $258.3M | $258.3M | $258.2M | $258.0M | $258.0M | $197.2M | $162.2M | $142.6M | $139.2M | |||||||||||
| Receivables Net Current | $398.0K | $722.0K | $959.0K | $837.0K | $837.0K | $778.0K | $859.0K | $964.0K | $238.0K | $813.0K | $448.0K | $619.0K | $625.0K | $495.0K | |||||||||||||
| Operating Lease Right Of Use Asset | $23.0K | $47.0K | $71.0K | $487.0K | $510.0K | $819.0K | $22.0K | $43.0K | $66.0K | $105.0K | $119.0K | $135.0K | |||||||||||||||
| Operating Lease Liability Current | $24.0K | $46.0K | $80.0K | $73.0K | $70.0K | $645.0K | $22.0K | $43.0K | $66.0K | $105.0K | $81.0K | $79.0K | |||||||||||||||
| Goodwill | $8.1M | $8.1M | $8.1M | $8.1M | $8.1M | $8.1M | $8.1M | $8.1M | $8.1M | $8.1M | $13.0M | $13.0M | $13.0M | ||||||||||||||
| Short Term Investments | $15.0K | $15.0K | $0.00 | $6.6M | $15.0K | $15.0K | $5.0M | $14.0K | $16.0K | $13.3M | $13.9M | $16.7M | $1.4M | ||||||||||||||
| Operating Lease Liability Noncurrent | $0.00 | $0.00 | $0.00 | $430.0K | $450.0K | $174.0K | $38.0K | $56.0K | |||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $18.7M | $16.9M | $20.0M | $22.1M | $11.1M | $15.2M | $19.4M | $23.0M | $18.5M | $27.0M | |||||||||||||||||
| Assets Of Disposal Group Including Discontinued Operation Current | $352.0K | $352.0K | $352.0K | $587.0K | $764.0K | $778.0K | $1.1M | $1.0M | |||||||||||||||||||
| Write Off Of Deferred Financing Costs Of At The Market Program | $0.00 | $0.00 | $0.00 | $0.00 | $142.0K | $121.0K | $115.0K | ||||||||||||||||||||
| Gain Loss On Sale Of Property Plant Equipment | $0.00 | -$13.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stock Issued During Period Value Share Based Compensation | $913.0K | $1.8M | $1.3M | $1.3M | $2.0M | $779.0K | |
| Share Based Compensation | $730.0K | $913.0K | $1.8M | $1.3M | $1.2M | $2.0M | |
| Net Cash Provided By Used In Operating Activities | -$14.9M | -$12.3M | -$15.9M | -$17.2M | -$14.3M | -$23.0M | |
| Net Cash Provided By Used In Investing Activities | $0.00 | $104.0K | $13.2M | -$3.5M | -$9.9M | $8.1M | |
| Payments To Acquire Short Term Investments | $15.0K | $6.6M | $5.0M | $34.9M | $9.8M | $1.9M | |
| Net Cash Provided By Used In Financing Activities | $14.0M | $7.4M | $304.0K | $0.00 | $59.5M | $13.2M | |
| Proceeds From Maturities Prepayments And Calls Of Shortterm Investments | $15.0K | $6.6M | $18.2M | $31.4M | $21.0K | $10.4M | |
| Proceeds From Issuance Of Common Stock | $0.00 | $304.0K | $0.00 | $59.3M | $7.0M | ||
| Increase Decrease In Working Capital | $2.8M | $5.9M | $3.0M | -$6.3M | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $0.00 | $127.0K | -$4.9M | -$747.0K | |||
| Payments For Proceeds From Productive Assets | $17.0K | $0.00 | $69.0K | $319.0K | |||
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $730.0K | $913.0K | |||||
| Increase Decrease In Receivables | -$596.0K | -$80.0K | $302.0K | ||||
| Increase Decrease In Prepaid Expense | $170.0K | -$315.0K | -$72.0K | ||||
| Increase Decrease In Accounts Payable Trade | -$84.0K | -$1.7M | $411.0K | ||||
| Proceeds From Stock Options Exercised | $0.00 | $21.0K | $0.00 | $118.0K | $45.0K | ||
| Proceeds From Warrant Exercises | $0.00 | $183.0K | $7.7M | ||||
| Payments For Proceeds From Financing Costs | $0.00 | $143.0K | -$7.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Issued During Period Value Share Based Compensation | $238.0K | $326.0K | $280.0K | $78.0K | $443.0K | $582.0K | $464.0K | $454.0K | $114.0K | $153.0K | -$30.0K | $377.0K | $635.0K | $642.0K | $670.0K | $252.0K | |||||||
| Share Based Compensation | $302.0K | $238.0K | $78.0K | $464.0K | $454.0K | $114.0K | $153.0K | -$30.0K | $401.0K | $632.0K | $2.0M | $611.0K | $650.0K | $250.0K | $777.0K | ||||||||
| Net Cash Provided By Used In Operating Activities | -$1.8M | -$3.6M | -$6.2M | -$5.4M | -$4.6M | -$6.1M | -$3.4M | -$4.2M | -$4.2M | -$4.2M | -$22.9M | -$7.1M | -$6.2M | -$6.8M | -$24.8M | ||||||||
| Net Cash Provided By Used In Investing Activities | $0.00 | -$15.0K | $0.00 | $13.3M | $557.0K | $2.8M | -$6.9M | -$1.4M | -$33.0K | -$36.0K | $8.1M | -$347.0K | $3.4M | $5.5M | -$9.4M | ||||||||
| Payments To Acquire Short Term Investments | $0.00 | $15.0K | $0.00 | $16.0K | $13.3M | $13.2M | $8.3M | $1.4M | $21.0K | $0.00 | $1.9M | $32.0K | $11.0K | $2.0M | $18.9M | ||||||||
| Net Cash Provided By Used In Financing Activities | -$327.0K | $0.00 | $0.00 | $195.0K | $0.00 | $0.00 | $0.00 | $19.7M | $3.4M | $1.6M | $13.2M | $7.1M | $6.6M | $34.0K | $45.7M | ||||||||
| Proceeds From Maturities Prepayments And Calls Of Shortterm Investments | $0.00 | $13.3M | $13.9M | $16.1M | $1.4M | $0.00 | $21.0K | $0.00 | $10.4M | -$61.0K | $3.4M | $7.6M | $9.9M | ||||||||||
| Proceeds From Issuance Of Common Stock | $0.00 | $195.0K | $0.00 | $0.00 | $19.7M | $3.4M | $1.8M | $6.0M | |||||||||||||||
| Increase Decrease In Working Capital | $1.3M | $683.0K | $2.6M | $533.0K | $2.0M | $2.2M | $1.2M | $3.0M | $2.0M | $1.2M | -$293.0K | -$6.3M | |||||||||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $51.0K | -$25.0K | -$978.0K | $872.0K | $2.7M | $238.0K | $572.0K | $345.0K | -$190.0K | $256.0K | |||||||||||||
| Payments For Proceeds From Productive Assets | $0.00 | $7.0K | $0.00 | $0.00 | $0.00 | $0.00 | $33.0K | $36.0K | $254.0K | $17.0K | |||||||||||||
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $108.0K | $206.0K | $302.0K | $160.0K | $202.0K | $238.0K | $326.0K | $280.0K | $78.0K | ||||||||||||||
| Increase Decrease In Receivables | -$106.0K | -$326.0K | $35.0K | ||||||||||||||||||||
| Increase Decrease In Prepaid Expense | $47.0K | $339.0K | $529.0K | ||||||||||||||||||||
| Increase Decrease In Accounts Payable Trade | $711.0K | $914.0K | -$1.4M | ||||||||||||||||||||
| Proceeds From Stock Options Exercised | $45.0K | $33.0K | $13.0K | $2.0K | |||||||||||||||||||
| Proceeds From Warrant Exercises | $7.7M | $1.1M | $6.6M | $34.0K | $796.0K | ||||||||||||||||||
| Payments For Proceeds From Financing Costs | $0.00 | $0.00 | $0.00 | $0.00 | $1.0K | $140.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.79 | -$1.35 | -$5.71 | -$0.27 | -$1.33 | -$0.30 | -$0.73 |
| Weighted Average Number Of Shares Outstanding Basic | 12.1M | 9.5M | 7.4M | 36.8M | |||
| Weighted Average Number Of Diluted Shares Outstanding | 12.1M | 9.5M | 7.4M | 36.8M | |||
| Earnings Per Share Basic | $-0.79 | $-1.35 | $-5.71 | $-0.27 | |||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 36.8M | 14.8M | 84.6M | 54.3M | |||
| Common Stock Shares Issued | 9.4M | 7.4M | 44.3M | ||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | ||||
| Common Stock Shares Outstanding | 7.4M | 44.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q4 2019 | Q3 2019 | Q2 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.14 | -$0.06 | -$0.21 | -$0.36 | -$0.30 | -$0.24 | -$0.21 | -$0.43 | -$0.54 | -$0.52 | -$0.66 | -$0.61 | -$0.09 | -$0.03 | -$0.12 | -$0.26 | -$0.52 | -$0.05 | -$0.14 | -$0.25 | -$0.11 | ||
| Weighted Average Number Of Shares Outstanding Basic | 16.9M | 15.9M | 15.9M | 11.5M | 11.5M | 10.9M | 11.5M | 7.6M | 7.4M | 7.4M | 7.4M | 7.4M | 44.3M | 32.8M | 26.0M | ||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 16.9M | 15.9M | 15.9M | 11.5M | 11.5M | 10.9M | 11.5M | 7.6M | 7.4M | 7.4M | 7.4M | 7.4M | 44.3M | 32.8M | 26.0M | ||||||||
| Earnings Per Share Basic | $-0.14 | $-0.06 | $-0.21 | $-0.36 | $-0.30 | $-0.24 | $-0.21 | $-0.43 | $-0.54 | $-0.52 | $-0.66 | $-0.61 | $-0.09 | $-0.03 | $-0.12 | ||||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 44.3M | 32.8M | 208.4M | 12.5M | 11.9M | 90.7M | 86.8M | 83.1M | 78.6M | ||||||||||||||
| Common Stock Shares Issued | 15.5M | 14.1M | 13.8M | 13.7M | 10.1M | 2.0M | 7.4M | ||||||||||||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||||||||
| Common Stock Shares Outstanding | 15.5M | 14.1M | 13.8M | 13.7M | 10.1M | 9.4M | 7.4M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Fair Value Adjustment Of Warrants | -$3.2M | $2.7M | -$10.0K | -$5.2M | $2.4M | $1.1M | $4.7M | ||
| Depreciation | $7.0K | $11.0K | $124.0K | $0.00 | $143.0K | $410.0K | $384.0K | ||
| Prepaid Expense Current | $283.0K | $598.0K | $720.0K | $343.0K | $977.0K | $835.0K | |||
| Additional Paid In Capital | $278.9M | $14.0M | $12.2M | $10.8M | $9.8M | $8.2M | |||
| Foreign Currency Transaction Gain Loss Unrealized | $0.00 | -$5.0K | $370.0K | -$814.0K | -$246.0K | ||||
| Investment Income Interest | $711.0K | $911.0K | $246.0K | ||||||
| Foreign Currency Transaction Gain Loss Realized | -$17.0K | -$16.0K | -$72.0K | ||||||
| Stock Issued During Period Value New Issues | $304.0K | $59.3M | $6.9M | ||||||
| Machinery And Equipment Gross | $24.0K | $104.0K | $250.0K | ||||||
| Increase Decrease Through Conversion Of Convertible Instruments | $120.0K | $40.0K | $40.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fair Value Adjustment Of Warrants | $40.0K | -$1.4M | $487.0K | $1.2M | -$362.0K | -$1.4M | -$125.0K | $1.8M | $0.00 | $0.00 | $0.00 | -$10.0K | -$828.0K | -$3.4M | -$643.0K | $1.1M | -$2.0M | $509.0K | $1.1M | $5.9M | $14.9M | $932.0K | $4.7M | |
| Depreciation | $2.0K | $1.0K | $7.0K | $167.0K | $0.00 | $0.00 | $0.00 | $0.00 | $56.0K | $86.0K | $410.0K | $110.0K | $72.0K | $89.0K | $384.0K | |||||||||
| Prepaid Expense Current | $519.0K | $416.0K | $500.0K | $453.0K | $583.0K | $477.0K | $622.0K | $811.0K | $1.0M | $1.1M | $1.0M | $1.4M | $1.5M | $1.8M | $2.2M | $1.4M | $559.0K | $489.0K | $718.0K | |||||
| Additional Paid In Capital | $298.2M | $293.8M | $293.6M | $293.3M | $279.5M | $18.3M | $18.1M | $17.6M | $17.3M | $14.0M | $13.6M | $13.2M | $12.6M | $11.5M | $11.1M | $11.0M | $10.8M | $10.9M | $10.4M | |||||
| Foreign Currency Transaction Gain Loss Unrealized | $0.00 | $10.0K | -$2.0K | $1.2M | -$740.0K | $54.0K | $20.0K | $134.0K | -$246.0K | $102.0K | -$64.0K | $60.0K | -$380.0K | |||||||||||
| Investment Income Interest | $170.0K | $172.0K | $205.0K | $138.0K | $172.0K | $235.0K | $316.0K | $212.0K | $134.0K | $67.0K | $36.0K | $32.0K | ||||||||||||
| Foreign Currency Transaction Gain Loss Realized | $4.0K | -$8.0K | $10.0K | -$16.0K | $13.0K | -$8.0K | $3.0K | -$13.0K | $8.0K | -$15.0K | -$12.0K | -$78.0K | ||||||||||||
| Stock Issued During Period Value New Issues | $4.3M | $0.00 | $0.00 | $0.00 | $109.0K | $195.0K | $0.00 | $19.6M | $3.4M | $1.8M | $6.0M | |||||||||||||
| Machinery And Equipment Gross | $11.0K | $12.0K | $14.0K | $15.0K | $19.0K | $21.0K | $23.0K | $12.0K | $10.0K | $84.0K | $112.0K | $122.0K | $90.0K | |||||||||||
| Increase Decrease Through Conversion Of Convertible Instruments |
Most recent annual filing with the SEC: June 23, 2025
Data sourced from SEC EDGAR public filings as of August 5, 2026.